NRC Institute for Biological Sciences
(NRC-IBS)

(Ottawa, Ontario)

Easing the Effects of Debilitating Diseases

NRC-IBS conducts innovative research in the application of neuro- and glycosciences to reduce the impact of age-related and infectious diseases. The Institute's programs are carried out with partners in industry, universities, hospitals, and other R&D organizations.

NRC-IBS research focuses on:

• Neurodegenerative diseases, such as stroke, Alzheimer's and Parkinson's
• Vaccines and immunotherapies against infectious diseases

Bacterial culture facility

NRC-IBS encompasses three major research programs:

The Neurobiology Program develops applications related to therapies for neurodegenerative disorders through its four research groups: Neurogenesis, Cerebrovascular Research, Synaptic Pathophysiology and Neurogenomics.

The Immunobiology Program conducts molecular-level research, through a multidisciplinary team, that leads to the development of novel vaccines and immunotherapeutics. These are pursued through the Immunomodulation, Infections and Immunity, Antibody Engineering and Molecular Pathogenesis groups.

The Glycobiology Program is aimed at developing carbohydrate-based therapeutics for infectious and neurodegenerative diseases. Research is carried out through five comprehensive research groups: Glycoanalysis, Genomics and Proteomics, Glycosidases, Eukaryotic Glycobiology, and Glycosyltransferases and Neuroglycomics.

NRC-IBS has a strong track record for transferring technology and knowledge to multinational, small- and medium-sized Canadian firms. NRC-IBS is also closely involved with national and international research networks.